All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
Asia Equity

Hansoh, Shimao net HK$5.8bn from primary blocks

Hong Kong island adobe stock 230x150

Hansoh Pharmaceutical Group, a China-based drug maker, pocketed HK$3.49bn ($450m) from a larger-than-planned issue of primary shares this week.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree